A triple combination therapy identified using newly developed cell models is showing promise for treating sporadic ALS, per a study.
Treatment with Evrysdi (risdiplam) may modestly improve arm function for adults with spinal muscular atrophy (SMA), a new study indicates.
A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone disease, for which there is currently no cure and which affects 5,000 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results